Zhejiang Garden Biopharmaceutical Co.,Ltd. (SHE:300401)
China
· Delayed Price · Currency is CNY 15.07
-0.03 (-0.20%)
Jun 4, 2025, 2:45 PM CST
SHE:300401 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 1,055 | 1,284 | 1,503 | 554.91 | 502.09 | 1,161 | Upgrade
|
| Trading Asset Securities | 201.25 | 140.25 | - | - | 0.4 | 200 | Upgrade
|
| Cash & Short-Term Investments | 1,257 | 1,425 | 1,503 | 554.91 | 502.49 | 1,361 | Upgrade
|
| Cash Growth | -27.14% | -5.20% | 170.83% | 10.43% | -63.08% | 124.67% | Upgrade
|
| Accounts Receivable | 188.85 | 157.74 | 92.78 | 169.66 | 90.46 | 74.41 | Upgrade
|
| Other Receivables | 1.23 | 0.73 | 0.8 | 1.21 | 0.41 | 1.55 | Upgrade
|
| Receivables | 190.08 | 158.47 | 93.57 | 170.87 | 90.87 | 75.96 | Upgrade
|
| Inventory | 794.92 | 838.23 | 780.04 | 545.87 | 429.94 | 319.9 | Upgrade
|
| Other Current Assets | 21.96 | 47.99 | 85.56 | 115.37 | 88.07 | 39.28 | Upgrade
|
| Total Current Assets | 2,264 | 2,469 | 2,462 | 1,387 | 1,111 | 1,796 | Upgrade
|
| Property, Plant & Equipment | 2,931 | 2,787 | 2,455 | 2,432 | 2,119 | 1,418 | Upgrade
|
| Other Intangible Assets | 207.83 | 182.73 | 172.23 | 165.77 | 165.87 | 180.17 | Upgrade
|
| Long-Term Accounts Receivable | 0.02 | 0.03 | - | - | - | - | Upgrade
|
| Long-Term Deferred Tax Assets | 33.19 | 36.27 | 40.41 | 19.76 | 11.51 | 21.87 | Upgrade
|
| Long-Term Deferred Charges | 30.89 | 26.52 | 24.52 | 25.46 | 16.61 | 7.44 | Upgrade
|
| Other Long-Term Assets | 69.67 | 110.86 | 106.01 | 101.97 | 105.67 | 146.19 | Upgrade
|
| Total Assets | 5,537 | 5,613 | 5,261 | 4,132 | 3,530 | 3,570 | Upgrade
|
| Accounts Payable | 369.56 | 340.54 | 327.87 | 443.02 | 329.59 | 158.64 | Upgrade
|
| Accrued Expenses | 12.09 | 63.14 | 50.42 | 60.83 | 47.21 | 36.23 | Upgrade
|
| Short-Term Debt | 291.78 | 462.79 | 408.68 | 532.39 | 414.37 | 240.36 | Upgrade
|
| Current Portion of Long-Term Debt | - | 198.16 | 254.51 | - | - | - | Upgrade
|
| Current Portion of Leases | - | 0.1 | - | - | 0.2 | - | Upgrade
|
| Current Income Taxes Payable | 14.79 | 23.41 | 16.56 | 18.5 | 15.32 | 10.99 | Upgrade
|
| Current Unearned Revenue | 32.28 | 21.26 | 19.55 | 55.03 | 34.87 | 9.45 | Upgrade
|
| Other Current Liabilities | 339.45 | 165.27 | 186.08 | 199.29 | 56.78 | 122.99 | Upgrade
|
| Total Current Liabilities | 1,060 | 1,275 | 1,264 | 1,309 | 898.34 | 578.65 | Upgrade
|
| Long-Term Debt | 1,064 | 1,054 | 923.27 | - | - | - | Upgrade
|
| Long-Term Unearned Revenue | 29.68 | 30.33 | 42.52 | 63.6 | 68.86 | 112.15 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 39.79 | 34.99 | 44.66 | 0.37 | 0.06 | - | Upgrade
|
| Other Long-Term Liabilities | - | - | 93.33 | 186.66 | 279.99 | - | Upgrade
|
| Total Liabilities | 2,194 | 2,394 | 2,367 | 1,560 | 1,247 | 690.8 | Upgrade
|
| Common Stock | 543.47 | 543.47 | 551.01 | 551.01 | 551.01 | 551.01 | Upgrade
|
| Additional Paid-In Capital | - | - | - | - | 2 | 1,031 | Upgrade
|
| Retained Earnings | 2,594 | 2,497 | 2,226 | 2,111 | 1,830 | 1,403 | Upgrade
|
| Treasury Stock | - | -26.86 | -140.42 | -53.72 | -100 | -100 | Upgrade
|
| Comprehensive Income & Other | 205.47 | 204.58 | 256.07 | -36.37 | - | - | Upgrade
|
| Total Common Equity | 3,343 | 3,218 | 2,893 | 2,572 | 2,283 | 2,885 | Upgrade
|
| Minority Interest | -0.01 | -0 | - | - | - | -6.23 | Upgrade
|
| Shareholders' Equity | 3,343 | 3,218 | 2,893 | 2,572 | 2,283 | 2,879 | Upgrade
|
| Total Liabilities & Equity | 5,537 | 5,613 | 5,261 | 4,132 | 3,530 | 3,570 | Upgrade
|
| Total Debt | 1,356 | 1,715 | 1,586 | 532.39 | 414.57 | 240.36 | Upgrade
|
| Net Cash (Debt) | -99.58 | -290.6 | -83.59 | 22.52 | 87.93 | 1,121 | Upgrade
|
| Net Cash Growth | - | - | - | -74.39% | -92.15% | 219.47% | Upgrade
|
| Net Cash Per Share | -0.17 | -0.49 | -0.14 | 0.04 | 0.16 | 2.21 | Upgrade
|
| Filing Date Shares Outstanding | 543.47 | 534.68 | 542.23 | 559.82 | 543.33 | 543.33 | Upgrade
|
| Total Common Shares Outstanding | 543.47 | 534.68 | 542.23 | 559.82 | 543.33 | 543.33 | Upgrade
|
| Working Capital | 1,204 | 1,195 | 1,198 | 77.97 | 213.04 | 1,217 | Upgrade
|
| Book Value Per Share | 6.15 | 6.02 | 5.34 | 4.59 | 4.20 | 5.31 | Upgrade
|
| Tangible Book Value | 3,135 | 3,036 | 2,721 | 2,406 | 2,117 | 2,705 | Upgrade
|
| Tangible Book Value Per Share | 5.77 | 5.68 | 5.02 | 4.30 | 3.90 | 4.98 | Upgrade
|
| Buildings | - | 1,473 | 1,377 | 1,180 | 490.73 | 377.95 | Upgrade
|
| Machinery | - | 1,149 | 938.79 | 844.74 | 360.6 | 327.79 | Upgrade
|
| Construction In Progress | - | 661.13 | 504.59 | 672.13 | 1,479 | 991.11 | Upgrade
|
Updated Oct 17, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.